News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

Dr. Reardon on the KEYNOTE-028 Trial of Pembrolizumab for GBM

Al's Comment:

Pembrolizumab (Keytruda) is approved for other types of cancer and can be used off label for GBMs.  This shows pretty good results, but it is a small trial and more research needs to be done.


Posted on: 11/24/2016

 Dr. Reardon on the KEYNOTE-028 Trial of Pembrolizumab for GBM

www.onclive.com/conference-coverage/sno-2016/dr-reardon-on-results-from-the-keynote028-trial-in-brain-cancer

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740